Systematic review of the efficacy, effectiveness and safety of high-dose seasonal influenza vaccines for the prevention of laboratory-confirmed influenza in individuals ≥18 years of age
This review sought to assess the efficacy, effectiveness and safety of high-dose inactivated influenza vaccines (HD-IIV) for the prevention of laboratory-confirmed influenza in individuals aged 18 years or older.
This Academic Publication is available from
Date of publication:
04 Feb 2022
Authors:
Laura Comber, Eamon O Murchu, Karen Jordan, Sarah Hawkshaw, Liam Marshall, Michelle O'Neill, Conor Teljeur, Máirín Ryan, AnnaSara Carnahan, Jaime Jesús Pérez Martín, Anna Hayman Robertson, Kari Johansen, Jorgen de Jonge, Tyra Krause, Nathalie Nicolay, Hanna Nohynek, Ioanna Pavlopoulou, Richard Pebody, Pasi Penttinen, Marta Soler-Soneira, Ole Wichmann, Patricia Harrington
Journal:
Reviews in Medical Virology
Digital object identifier:
DOI: 10.1002/rmv.2330
Type of output:
Evidence synthesis
Suggested Citation:
Comber L, O Murchu E, Jordan K, Hawkshaw S, Marshall L, O’Neill M, Teljeur C, Ryan M, Carnahan A, Pérez Martín JJ, Hayman Robertson A, Johansen K, de Jonge J, Krause T, Nicolay N, Nohynek H, Pavlopoulou I, Pebody R, Penttinen P, Soler-Soneira M, Wichmann O & Harrington P. Systematic review of the efficacy, effectiveness and safety of high-dose seasonal influenza vaccines for the prevention of laboratory-confirmed influenza in individuals ≥18 years of age. Reviews in Medical Virology. 2022;e2330.